SCHEMBL4217857

SCHEMBL4217857

NC(=O)CCC1=CCOc2ccc(OCc3ccccc3)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.46
MAOA P21397 4/20 0.46
ALOX5 P09917 2/20 0.45
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
NFKB1 P19838 1/20 0.43
GRM5 P41594 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PARP10 Q53GL7 1/20 0.42
FFAR1 O14842 2/20 0.42
FFAR4 Q5NUL3 1/20 0.41
TOP1 P11387 1/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4206464 0.91 MAOB (0.53) MAOBMAOAALOX5NPC1RAB9A
SCHEMBL4210087 0.82 MAOB (0.55) MAOBMAOAALOX5NPC1RAB9A
SCHEMBL4209941 0.81 MAOB (0.55) MAOBMAOAGRM5PARP10
SCHEMBL4206480 0.80 MAOB (0.50) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL4211572 0.78 MAOB (0.50) MAOBMAOAALOX5NPC1RAB9A
SCHEMBL4213101 0.78 MAOB (0.50) MAOBMAOAALOX5NPC1RAB9A
SCHEMBL12214584 0.77 MAOB (0.57) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL4215975 0.76 MAOB (0.55) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL4224787 0.75 MAOB (0.52) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL4213237 0.73 MAOB (0.52) MAOBMAOAALOX5NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005436-A1 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives NEWRON PHARMACEUTICALS S.P.A. (IT) 2009-01-01 US claimed
CN-101137638-A Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives NEWRON PHARM SPA (IT) 2008-03-05 CN claimed
US-6841480-B2 Polyelectrolyte dispensing polishing pad, production thereof and method of polishing a substrate INFINEON TECHNOLOGIES AG (DE) 2005-01-11 US claimed
EP-1557669-B1 Use of a gas sensing material and gas inspecting method FUJIFILM CORP (JP) 2014-09-24 EP disclosed
US-7497107-B2 Gas sensing material and gas inspecting method FUJI PHOTO FILM CO., LTD. (JP) 2009-03-03 US disclosed
US-20090005436-A1 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives NEWRON PHARMACEUTICALS S.P.A. (IT) 2009-01-01 US disclosed
CN-101137638-A Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives NEWRON PHARM SPA (IT) 2008-03-05 CN disclosed
EP-1863784-A1 SUBSTITUTED AMINOALKYL- AND AMIDOALKYL-BENZOPYRAN DERIVATIVES Newron Pharmaceuticals S.p.A. (IT) 2007-12-12 EP disclosed
WO-2006102958-A1 SUBSTITUTED AMINOALKYL- AND AMIDOALKYL-BENZOPYRAN DERIVATIVES NEWRON PHARMACEUTICALS S.P.A. (IT) 2006-10-05 WO disclosed
US-20050207944-A1 Gas sensing material and gas inspecting method FUJI PHOTO FILM CO., LTD. (JP) 2005-09-22 US disclosed
EP-1557669-A1 Gas sensing material and gas inspecting method FUJI PHOTO FILM CO., LTD. (JP) 2005-07-27 EP disclosed
US-6458519-B1 SUPPORT, SILVER HALIDE, ORGANIC SILVER SALT AND REDUCING AGENT; ANTIFOGGING, STABILITY KONICA CORPORATION (JP) 2002-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005436-A1 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives MAOB, MAOA, AOC3 MAOB 1/4885MAOA 2/4885ALOX5 580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.